Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Winners or losers? Two academic years in experiences of COVID-19 pandemic
Ivana Milovanović, Radenko Matić, Brigita Banjac, Saša Pišot
Izvirni znanstveni članek
Oznake: students;everyday practice;e-learning;perspective of the future;fear;loneliness;COVID-19 pandemic measures;public health;
Background. The COVID-19 pandemic declared on March 11th, 2020, has had a substantial impact on the lives of all over the world. The student population, being one of the most vulnerable and substile ones, was forced to face specific unexpected circumstances for the first time in their lives. Objecti ...
Leto: 2024 Vir: Univerza na Primorskem (UP)
Exploring the well-being of Slovenian and Serbian sport science students during the covid-19 pandemic of summer 2022
Brigita Banjac, Ivana Milovanović, Saša Pišot, Radenko Matić, Stevo Popović, Sandra Radenović, Patrik Drid
Izvirni znanstveni članek
Oznake: zdravstvene vede;sport;health science;physical education;university students;pandemics;mental health;well-being;
The COVID-19 pandemic profoundly changed everyday life of social actors, which inferred mental health and well-being concerns. As students of health-related studies tend to adapt better to difficult circumstances, in this study, we explored the effect of the pandemic on sports science students’ well ...
Leto: 2023 Vir: Repozitorij Univerze na Primorskem (RUP)
Real-world data on detection of germline and somatic pathogenic/likely pathogenic variants in BRCA1/2 and other susceptibility genes in ovarian cancer patients using next generation sequencing
Vida Stegel, Ana Blatnik, Erik Škof, Vita Šetrajčič Dragoš, Mateja Krajc, Brigita Gregorčič, Petra Cerkovnik, Ksenija Strojnik, Gašper Klančar, Marta Banjac, Janez Žgajnar, Maja Ravnik-Oblak, Srdjan Novaković
Izvirni znanstveni članek
Oznake: BRCA;rak jajčnikov;genotip tumorja;HBOC;ovarian cancer;tumor genotyping;
Detection of germline and somatic pathogenic/likely pathogenic variants (PV/LPV) in BRCA genes is at the moment a prerequisite for use of PARP inhibitors in different treatment settings of different tumors. The aim of our study was to determine the most appropriate testing workflow in epithelial ova ...
Leto: 2022 Vir: Onkološki inštitut Ljubljana (OI)
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: